The Scottish Medicines Consortium (SMC) have approved revolutionary drug, Kadcyla for use on the NHS in Scotland.
Breast Cancer Now teamed up with four Scottish mums; Lesley, Alison, Lesley and Anne, to launch a petition asking the drug’s manufacturer, Roche and the SMC - to reach a deal on this life-changing drug that will see it made available in Scotland.
The petition to unlock Kadcyla on Scotland’s NHS closed with a 13,196 signatures in just six days.
On Monday 10 April 2017 the SMC announced a landmark decision to make the revolutionary breast cancer drug, Kadcyla, routinely available on Scotland’s NHS. The decision will transform treatment options for women with HER2 positive secondary breast cancer in Scotland.
Mary Allison, Breast Cancer Now’s Director for Scotland said:
This decision will transform treatment options for women with HER2 positive secondary breast cancer in Scotland.
I’d like to thank everyone who supported the Unlock Kadcyla petition, but most of all the four inspirational women who were the driving force behind the campaign. This success belongs to our campaigners Anne, Lesley, Alison and Lesley, who joined with us to launch the petition.
We are pleased that the SMC and Roche have worked together to unlock this revolutionary drug. We hope this will be just the start of improved access to breast cancer medicines in Scotland.
Both the Scottish Government and Breast Cancer Now share the same vision of making sure that by 2050 everyone who develops breast cancer will live. If we are to achieve this, we’ll need to ensure that patients in Scotland are able to access the best possible treatments – and today is a real step forward for women with HER2 positive disease.”